Stabile Giuseppe, Solimene Francesco, Calò Leonardo, Anselmino Matteo, Castro Antonello, Pratola Claudio, Golia Paolo, Bottoni Nicola, Grandinetti Giuseppe, De Simone Antonio, Schillaci Vincenzo, Bertaglia Emanuele, De Ponti Roberto
Laboratorio di Elettrofisiologia, Clinica Mediterranea, Via Orazio 2, 80122, Naples, Italy,
J Interv Card Electrophysiol. 2015 Jan;42(1):21-6. doi: 10.1007/s10840-014-9947-2. Epub 2014 Nov 7.
Catheter-tissue contact is critical for effective lesion creation in radiofrequency catheter ablation (RFCA). In a multicenter prospective study, we assessed the relationship between catheter contact force (CF) during RFCA for paroxysmal atrial fibrillation (AF) and clinical recurrences over a mid-term follow-up.
All patients underwent RFCA for paroxysmal AF by antral pulmonary vein (PV) isolation, aiming at entry and exit conduction block in all PVs. A new open-irrigated tip catheter with CF sensing (SmartTouch(TM), Biosense Webster Inc. CA) was used. All patients were followed for at least 12 months and the relationship between CF and clinical outcomes assessed.
One year follow-up was available in 92/95 of the patients enrolled. Acute PV isolation was achieved in 100 % of the veins. Mean CF during RFCA was 12.2 ± 3.9 g. Mean force-time integral (FTI) was 733 ± 505 gs. Following the 3-month blanking period, 17 (18 %) patients experienced at least 1 atrial tachyarrhythmia relapse. There was no statistical difference in mean CF (13 ± 3.4 g vs 12 ± 4 g, p = 0.32) and mean FTI (713 ± 487 gs vs 822 ± 590 gs, p = 0.42) between patients with and without arrhythmia recurrences. Recurrences were recorded in 22 % of patients achieving a mean FTI value below the median of 544 gs and in 15 % of patients with a mean FTI value above the median (p = 0.64).
RFCA with CF data during PV isolation for paroxysmal AF improves physician's knowledge on catheter-tissue contact. In the present dataset, however, higher CF values did not impact mid-term clinical RFCA outcome.
在射频导管消融(RFCA)中,导管与组织的接触对于有效形成损伤至关重要。在一项多中心前瞻性研究中,我们评估了阵发性心房颤动(AF)射频消融过程中导管接触力(CF)与中期随访期间临床复发之间的关系。
所有患者均通过肺静脉前庭隔离术进行阵发性房颤的射频消融,目标是所有肺静脉实现入路和出路传导阻滞。使用了一种新型带CF传感的开放式灌注尖端导管(SmartTouch™,美国加利福尼亚州Biosense Webster公司)。所有患者均随访至少12个月,并评估CF与临床结果之间的关系。
95例入组患者中有92例完成了1年随访。所有肺静脉均实现了急性隔离。射频消融期间的平均CF为12.2±3.9克。平均力-时间积分(FTI)为733±505克秒。在3个月的空白期后,17例(18%)患者经历了至少1次房性快速性心律失常复发。有和没有心律失常复发的患者之间,平均CF(13±3.4克对12±4克,p = 0.32)和平均FTI(713±487克秒对822±590克秒,p = 0.42)没有统计学差异。平均FTI值低于中位数544克秒的患者中有22%记录到复发,平均FTI值高于中位数的患者中有15%记录到复发(p = 0.64)。
阵发性房颤肺静脉隔离期间结合CF数据的射频消融提高了医生对导管与组织接触的认识。然而,在本数据集中,较高的CF值并未影响射频消融的中期临床结果。